Clinical Trial

DCE MRI in Patients with Pancreatic Cancer

Study Description

DCE MRI in Patients With Pancreatic Cancer

This clinical trial studies an imaging technique known as dynamic contrast enhanced magnetic resonance imaging (DCE MRI) in identifying the presence of pancreatic cancer. DCE MRI is a procedure that takes detailed pictures of functional and structural properties inside the body using magnetic field imaging. These images may better characterize pancreatic cancer in patients at high risk or in patients who have undergone chemotherapy for pancreatic cancer.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Procedure - Dynamic Contrast-Enhanced Magnetic Resonance Imaging

Undergo DCE MRI

Drug - Ferumoxytol

Given IV

Additional Information

Official Study Title

The Use of Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE MRI) in the Management of Pancreatic Cancer

Clinical Trial ID

NCT02070705

ParticipAid ID

0dN0Ka